Literature DB >> 26201180

[The application of extended supraglottic horizontal partial laryngectomy in advanced laryngeal carcinoma and vallecula carcinoma].

Xudong Zhao, Wenyue Ji.   

Abstract

OBJECTIVE: To discuss the function recovery and treatment effect of extended supraglottic orizontal-partial laryngectomy in the treatment of advanced laryngeal carcinoma and vallecula carcinoma.
METHOD: Forty-four patients who received extended supraglottic orizontal partial laryngectomy were followed up on the survival, breath function, pronunciation and swallowing function. RESULT: The 2-year, 3-year survival rates of this group were 72.7% and 71.4%, respectively. There were no recurrence cases in this group. All cases of death were due to cervical lymph node metastasis or recurrent cervical lymph node metastasis after cervical lymph node dissection. The extractive rate of tracheostomy tube was 97.7%. Forty-two patients own good pronunciations. Two patients who received partial arytenoid cartilage resection own weaker pronunciations. After practising, all the patients can eat without the nasal feeding tube.
CONCLUSION: Extended supraglottic orizontalpartial laryngectomy give complete resection of the primary lesion. Patients who received extended supraglottic orizontalpartial laryngectomy have good breath, swallowing and pronunciation function.

Entities:  

Mesh:

Year:  2015        PMID: 26201180

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  2 in total

1.  Swallowing, voice and quality of life of patients submitted to extended supratracheal laryngectomy.

Authors:  Guilherme Maia Zica; Andressa Silva de Freitas; Ana Catarina Alves E Silva; Fernando Luiz Dias; Izabella Costa Santos; Emilson Queiroz Freitas; Hilton Augusto Koch
Journal:  Einstein (Sao Paulo)       Date:  2020-05-18

2.  Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy.

Authors:  Mei-Jia Zhang; Ji-Wei Mu; Xiu-Sheng Qu; Chong Feng; Wei Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.